Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)
China · Delayed Price · Currency is CNY 65.71
-0.42 (-0.64%)
Apr 21, 2026, 3:00 PM CST
SHA:688513 Market Cap
SHA:688513 has a market cap or net worth of 11.46 billion as of April 20, 2026. Its market cap has increased by 115.01% in one year.
Market Cap
11.46B
Enterprise Value
10.02B
Revenue
1.33B
Ranking
n/a
PE Ratio
40.31
Stock Price
65.71
Market Cap Chart
Since September 2, 2020, SHA:688513's market cap has increased from 8.97B to 11.46B, an increase of 27.68%. That is a compound annual growth rate of 4.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 11.53B | 7.44% |
| Dec 31, 2025 | 10.73B | 104.34% |
| Dec 31, 2024 | 5.25B | -31.43% |
| Dec 29, 2023 | 7.66B | 4.83% |
| Dec 30, 2022 | 7.31B | 31.12% |
| Dec 31, 2021 | 5.57B | -2.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chengzhi | 12.97B |
| Vcanbio Cell & Gene Engineering Corp., | 12.91B |
| InventisBio | 12.76B |
| Pacific Shuanglin Bio-pharmacy | 12.24B |
| Hualan Biological Vaccine | 11.85B |
| Chengdu Olymvax Biopharmaceuticals | 11.81B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 11.51B |
| Chongqing Genrix Biopharmaceutical | 11.41B |